Eribulin Mesylate Injection
Product Images NDC 71731-4171

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 71731-4171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Draft Carton Label (Draft Carton Label)

Draft Carton Label (Draft Carton Label)
This text provides information about Eribulin Mesylate Injection, a medication indicated for intravenous use and containing a cytotoxic agent. Each single-dose vial contains 1 mg of Eribulin Mesylate in 2 mL of solution. The dosage and use instructions should be followed as per the accompanying prescribing information. The medication should be stored between 15°C to 30°C (59°F to 86°F) and should not be frozen or refrigerated. It is important to discard any unused portion of the single-dose vial.*
FDA Label Image

Draft Container Label (Draft Container Label)

Draft Container Label (Draft Container Label)
This text provides information on Eribulin Mesylate Injection in a 1 mg/2 mL (0.5 mg/ml) dosage for intravenous use. It emphasizes that it is a single-dose vial, and any unused portion must be discarded. The solution is sterile and should be stored between 20°C to 25°C (68°F to 77°F). It cautions against freezing or refrigerating the product due to its cytotoxic nature. The manufacturer is The WhiteOak Group, LLC, based in Washington DC, with the product being made in China. It also mentions that the dosage and usage instructions are available in the accompanying prescribing information.*
FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
FDA Label Image

Figure 2 (Fig 2)

Figure 2 (Fig 2)
FDA Label Image

Formula Structure (Figure 01 Formula Structure)

Formula Structure (Figure 01 Formula Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.